|
Education |
Master of Health Sciences - University of South Alabama, PA Studies, College of
Allied Health Completion date: August 2004; Class Treasurer 2002-2004
Bachelor of Science in Bacteriology - Washington State University College of Art
and Sciences Graduated: June 1978 |
|
|
|
Licenses and Certifications
|
Georgia Physician’s Assistant license
American Heart Association Basic Life Support
American Heart Association Advanced Cardiac Life Support Provider |
|
|
|
Continuing Education |
AAPP GCP Course Atlanta, GA 11/6-7/2004
Pelvic Floor Muscle Rehabilitation for Incontinence-1/22-22/2005
Fundamentals of Urodynamics-November 11/12/2005 |
|
|
|
Research |
|
Urology-Stress Urinary Incontinence/Overactive Bladder
|
Protocol: F1J-US-SBCD Eli Lilly and Omnicare Pharmaceuticals 2003
Study ********** in Women of Different Demographic Characteristics and Co-morbidities
with Stress Urinary Incontinence: Evaluation of Efficacy and Safety. |
|
|
|
Urology-Benign Prostatic Hyperplasia (BPH)/Prostatitis |
|
Protocol: L8890 Sponsor- Sanofi Synthelabo 2004Prospective, observational
registry and patient survey of the management of men with symptomatic benign Prostatic
hyperplasia. |
|
|
Protocol: CAPSS-292 Ortho-McNeil Pharmaceuticals 2004
Randomized, Parallel Group Trial of Ditropan XL extended release tablets or placebo
in combination with Flomax for the treatment of lower urinary symptoms. |
|
|
|
Urology-Urinary Tract Infections |
Protocol: CAPSS-349 Ortho-McNeil Pharmaceuticals 2005
A Study to Compare the Safety and Efficacy of Once Daily ****** versus Twice Daily
***** in the Treatment of Complicated Urinary Tract Infection and Acute Uncomplicated
Pyelonephritis. |
|
|
|
Urology-Prostate Cancer |
|
|
|
Protocol: L8891 Sanofi-Synthelabo 2004Prospective, Observational
Registry of the management of men with prostate cancer and a rising PSA following
surgical or radiological treatment of the primary tumor. |
|
|
|
Protocol: G300203 GTX Inc. 2005A randomized, Double-Blind, Placebo-Controlled,
Multicenter Efficacy and Safety of ***** ** for the Prevention of Bone Fractures
in Men with Prostate Cancer on Androgen Deprivation Therapy. |
|
|
|
Protocol: 20050103 A Randomized, Double-Blind, Multicenter study
of ******** Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases
in Men with Hormone-Refractory Prostate Cancer. |
|
|
|
Protocol: 20050147A Randomized, Double-Blind, Placebo-Controlled,
Multi-Center Phase III Study of ******* on Prolonging Bone Metastasis-Free Survival
in Men with Hormone-Refractory Prostate Cancer. |
|
|
|
Urology-Adult Growth Hormone Deficiency |
|
|
|
Protocol: X3397nThe Incidence of Adult Growth Hormone Deficiency
Secondary to Pituitary Adenomas and Head trauma in Hypogonadal Males Presenting
in the Urological Practice. |
|
|
|
Protocol: L3339n Principle InvestigatorGenentech National Cooperative
Metabolic Study (NCMS) of Nutropin AQ [somatropin (rDNA origin) injection] and Nutropin
[somatropin (rDNA origin) for injection] Replacement Therapy in Adults with Growth
Hormone Deficiency. |
|
|
|
Urology-Interstitial Cystitis |
Protocol MN-001-CL-002 Principle Investigator
A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter study to Evaluate
the Efficacy and Safety of Two Dosing Regimens of ***** in Patients with Interstitial
Cystitis. |